Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Syndrome, CNS Demyelinating”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Not applicableStudy completedNCT00787657
What this trial is testing

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Bayer 1,723
Not applicableLooking for participantsNCT06455332
What this trial is testing

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University Hospital, Lille 200
Not applicableStudy completedNCT03451955
What this trial is testing

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Who this might be right for
Optic NeuritisMultiple SclerosisClinically Isolated Syndrome
University of Copenhagen 103
Testing effectiveness (Phase 2)Study completedNCT01728922
What this trial is testing

Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University College Dublin 64
Post-approval studies (Phase 4)Study completedNCT03269175
What this trial is testing

BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies

Who this might be right for
Multiple Sclerosis
Bayer 261
Not applicableStudy completedNCT04038541
What this trial is testing

Prebiotic vs Probiotic in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome (CIS)
Columbia University 37
Not applicableStudy completedNCT01592474
What this trial is testing

Evaluation of Brain Atrophy in CIS Patients on Avonex

Who this might be right for
Multiple Sclerosis
University at Buffalo 180
Not applicableStudy completedNCT01865357
What this trial is testing

Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI

Who this might be right for
Clinically Isolated Demyelinating SyndromesMultiple SclerosisCognitive Deficiencies+1 more
University Hospital, Bordeaux 117
Not applicableEnded earlyNCT04746976
What this trial is testing

Study of Diroximel Fumarate in the Real-World Setting

Who this might be right for
Relapsing Forms of MS
Biogen 75
Not applicableUnknownNCT02361697
What this trial is testing

DTI in Children With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis - Relapsing RemittingClinically Isolated Syndrome, CNS Demyelinating
University Hospital Muenster 15
Not applicableStudy completedNCT00704834
What this trial is testing

Gene Expression Profiles in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of California, Davis 46
Not applicableStudy completedNCT02671682
What this trial is testing

Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Albert Christian Ludolph, Prof. 61
Post-approval studies (Phase 4)Ended earlyNCT01411514
What this trial is testing

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 27
Not applicableEnded earlyNCT01567553
What this trial is testing

The Inflammatory Process and the Medical Imaging in Patients With an Inflammatory Disease of the Central Nervous System.

Who this might be right for
Multiple Sclerosis (MS)Inflammatory Disease
Rennes University Hospital 37
Not applicableStudy completedNCT01414816
What this trial is testing

Betaferon® Regulatory Post-Marketing Surveillance

Who this might be right for
Multiple SclerosisClinically Isolated System
Bayer 355
Not applicableStudy completedNCT00232193
What this trial is testing

Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS

Who this might be right for
Relapsing-remitting Multiple SclerosisClinically Isolated Syndrome
Providence Multiple Sclerosis Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01413243
What this trial is testing

Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Charite University, Berlin, Germany 50
Not applicableLooking for participantsNCT07135752
What this trial is testing

Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination

Who this might be right for
Radiologically Isolated Syndromes; Multiple Sclerosis
Centre Hospitalier Universitaire de Nice 150
Large-scale testing (Phase 3)Study completedNCT00622700
What this trial is testing

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 618
Not applicableStudy completedNCT01112657
What this trial is testing

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 154
Load More Results